The expression of S100A9 was significantly elevated in the in vitro model of endotoxin tolerance, suggesting that S100A9 may be a novel biomarker of endotoxin tolerance and providing valuable information for immunotherapy in patients with sepsis shock (38). The gene discussed is S100A9; the disease is Sepsis.